Structure–activity relationships of sugar-based peptidomimetics as modulators of amyloid β-peptide early oligomerization and fibrillization

Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid β peptides. Aβ1–42 being the most aggregative and neurotoxic amyloid peptide, we report herein the capacity of sugar-based pentapeptide analogs to modulate the Aβ1–42 aggregation process...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of medicinal chemistry Vol. 86; pp. 752 - 758
Main Authors Kaffy, Julia, Brinet, Dimitri, Soulier, Jean-Louis, Khemtémourian, Lucie, Lequin, Olivier, Taverna, Myriam, Crousse, Benoît, Ongeri, Sandrine
Format Journal Article
LanguageEnglish
Published ISSY-LES-MOULINEAUX Elsevier Masson SAS 30.10.2014
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid β peptides. Aβ1–42 being the most aggregative and neurotoxic amyloid peptide, we report herein the capacity of sugar-based pentapeptide analogs to modulate the Aβ1–42 aggregation process using thioflavin fluorescence and transmission electron microscopy assays. The importance of the free hydroxyl groups of the sugar moiety, used as a β-breaker element, is confirmed since hydroxylated compounds inhibit the aggregation process while benzylated ones enhance it. Furthermore, the most effective molecules were also evaluated by a recently developed capillary electrophoresis method, providing in vitro monitoring of the crucial, very early stages of the self-assembly process. This technique allowed us to investigate the effect of these compounds on the small non-fibrillar Aβ1–42 oligomers suspected by several groups worldwide as highly neurotoxic. We clearly demonstrated that molecules delaying the aggregation can stabilize the monomeric peptide or promote the formation of soluble oligomeric species. In contrast, molecules that accelerate the aggregation can prevent the presence of small toxic oligomers. [Display omitted] •Structure–activity relationships of Sugar-based pentapeptide analogs.•Two hydrophobic dipeptides are linked to a d-glucopyranosyl scaffold.•The molecules delay or accelerate the kinetics of β-amyloid early oligomerization.•The early oligomerization is monitored by capillary electrophoresis.
AbstractList Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid β peptides. Aβ1–42 being the most aggregative and neurotoxic amyloid peptide, we report herein the capacity of sugar-based pentapeptide analogs to modulate the Aβ1–42 aggregation process using thioflavin fluorescence and transmission electron microscopy assays. The importance of the free hydroxyl groups of the sugar moiety, used as a β-breaker element, is confirmed since hydroxylated compounds inhibit the aggregation process while benzylated ones enhance it. Furthermore, the most effective molecules were also evaluated by a recently developed capillary electrophoresis method, providing in vitro monitoring of the crucial, very early stages of the self-assembly process. This technique allowed us to investigate the effect of these compounds on the small non-fibrillar Aβ1–42 oligomers suspected by several groups worldwide as highly neurotoxic. We clearly demonstrated that molecules delaying the aggregation can stabilize the monomeric peptide or promote the formation of soluble oligomeric species. In contrast, molecules that accelerate the aggregation can prevent the presence of small toxic oligomers. [Display omitted] •Structure–activity relationships of Sugar-based pentapeptide analogs.•Two hydrophobic dipeptides are linked to a d-glucopyranosyl scaffold.•The molecules delay or accelerate the kinetics of β-amyloid early oligomerization.•The early oligomerization is monitored by capillary electrophoresis.
Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid β peptides. Aβ1-42 being the most aggregative and neurotoxic amyloid peptide, we report herein the capacity of sugar-based pentapeptide analogs to modulate the Aβ1-42 aggregation process using thioflavin fluorescence and transmission electron microscopy assays. The importance of the free hydroxyl groups of the sugar moiety, used as a β-breaker element, is confirmed since hydroxylated compounds inhibit the aggregation process while benzylated ones enhance it. Furthermore, the most effective molecules were also evaluated by a recently developed capillary electrophoresis method, providing in vitro monitoring of the crucial, very early stages of the self-assembly process. This technique allowed us to investigate the effect of these compounds on the small non-fibrillar Aβ1-42 oligomers suspected by several groups worldwide as highly neurotoxic. We clearly demonstrated that molecules delaying the aggregation can stabilize the monomeric peptide or promote the formation of soluble oligomeric species. In contrast, molecules that accelerate the aggregation can prevent the presence of small toxic oligomers.
Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid beta peptides. A beta(1-42) being the most aggregative and neurotoxic amyloid peptide, we report herein the capacity of sugar-based pentapeptide analogs to modulate the A beta(1-42) aggregation process using thioflavin fluorescence and transmission electron microscopy assays. The importance of the free hydroxyl groups of the sugar moiety, used as a beta-breaker element, is confirmed since hydroxylated compounds inhibit the aggregation process while benzylated ones enhance it. Furthermore, the most effective molecules were also evaluated by a recently developed capillary electrophoresis method, providing in vitro monitoring of the crucial, very early stages of the self-assembly process. This technique allowed us to investigate the effect of these compounds on the small non-fibrillar A beta(1-42) oligomers suspected by several groups worldwide as highly neurotoxic. We clearly demonstrated that molecules delaying the aggregation can stabilize the monomeric peptide or promote the formation of soluble oligomeric species. In contrast, molecules that accelerate the aggregation can prevent the presence of small toxic oligomers. (c) 2014 Elsevier Masson SAS. All rights reserved.
: Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid β peptides. Aβ1-42 being the most aggregative and neurotoxic amyloid peptide, we report herein the capacity of sugar-based pentapeptide analogs to modulate the Aβ1-42 aggregation process using thioflavin fluorescence and transmission electron microscopy assays. The importance of the free hydroxyl groups of the sugar moiety, used as a β-breaker element, is confirmed since hydroxylated compounds inhibit the aggregation process while benzylated ones enhance it. Furthermore, the most effective molecules were also evaluated by a recently developed capillary electrophoresis method, providing in vitro monitoring of the crucial, very early stages of the self-assembly process. This technique allowed us to investigate the effect of these compounds on the small non-fibrillar Aβ1-42 oligomers suspected by several groups worldwide as highly neurotoxic. We clearly demonstrated that molecules delaying the aggregation can stabilize the monomeric peptide or promote the formation of soluble oligomeric species. In contrast, molecules that accelerate the aggregation can prevent the presence of small toxic oligomers.
Author Ongeri, Sandrine
Lequin, Olivier
Soulier, Jean-Louis
Crousse, Benoît
Brinet, Dimitri
Taverna, Myriam
Kaffy, Julia
Khemtémourian, Lucie
Author_xml – sequence: 1
  givenname: Julia
  surname: Kaffy
  fullname: Kaffy, Julia
  organization: Molécules Fluorées et Chimie Médicinale, BioCIS UMR-CNRS 8076, LabEx LERMIT, Université Paris-Sud, Faculté de Pharmacie, 5 Rue Jean-Baptiste Clément, 92296 Châtenay-Malabry Cedex, France
– sequence: 2
  givenname: Dimitri
  surname: Brinet
  fullname: Brinet, Dimitri
  organization: Molécules Fluorées et Chimie Médicinale, BioCIS UMR-CNRS 8076, LabEx LERMIT, Université Paris-Sud, Faculté de Pharmacie, 5 Rue Jean-Baptiste Clément, 92296 Châtenay-Malabry Cedex, France
– sequence: 3
  givenname: Jean-Louis
  surname: Soulier
  fullname: Soulier, Jean-Louis
  organization: Molécules Fluorées et Chimie Médicinale, BioCIS UMR-CNRS 8076, LabEx LERMIT, Université Paris-Sud, Faculté de Pharmacie, 5 Rue Jean-Baptiste Clément, 92296 Châtenay-Malabry Cedex, France
– sequence: 4
  givenname: Lucie
  surname: Khemtémourian
  fullname: Khemtémourian, Lucie
  organization: Sorbonne Universités – UPMC Univ Paris 06, Ecole Normale Supérieure – PSL Research University, CNRS UMR 7203 LBM, 4 Place Jussieu, 75252 Paris Cedex 05, France
– sequence: 5
  givenname: Olivier
  surname: Lequin
  fullname: Lequin, Olivier
  organization: Sorbonne Universités – UPMC Univ Paris 06, Ecole Normale Supérieure – PSL Research University, CNRS UMR 7203 LBM, 4 Place Jussieu, 75252 Paris Cedex 05, France
– sequence: 6
  givenname: Myriam
  surname: Taverna
  fullname: Taverna, Myriam
  organization: Protéines et Nanotechnologies en Sciences Séparatives, Institut Galien de Paris Sud, UMR-CNRS 8612, Université Paris-Sud, Faculté de Pharmacie, 5 Rue Jean-Baptiste Clément, 92296 Châtenay-Malabry Cedex, France
– sequence: 7
  givenname: Benoît
  surname: Crousse
  fullname: Crousse, Benoît
  organization: Molécules Fluorées et Chimie Médicinale, BioCIS UMR-CNRS 8076, LabEx LERMIT, Université Paris-Sud, Faculté de Pharmacie, 5 Rue Jean-Baptiste Clément, 92296 Châtenay-Malabry Cedex, France
– sequence: 8
  givenname: Sandrine
  surname: Ongeri
  fullname: Ongeri, Sandrine
  email: sandrine.ongeri@u-psud.fr
  organization: Molécules Fluorées et Chimie Médicinale, BioCIS UMR-CNRS 8076, LabEx LERMIT, Université Paris-Sud, Faculté de Pharmacie, 5 Rue Jean-Baptiste Clément, 92296 Châtenay-Malabry Cedex, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25238173$$D View this record in MEDLINE/PubMed
https://hal.science/hal-01067196$$DView record in HAL
BookMark eNqNkc-O0zAQhy20iO0uvAFCviKU4D9JnFyQVhWwSJU4AGfLsSdbV0lc2U5X5cQT7GXfhAfhIXgS3Kb0iDhYY42-b6SZ3xW6GN0ICL2kJKeEVm83OWwG0OucEVrkpMkJp0_Qgoqqzjgriwu0IIzxrGS8uERXIWwIIWVFyDN0yVKzpoIv0MOX6CcdJw-_fzwqHe3Oxj320Kto3RjWdhuw63CY7pTPWhXA4C1sozVusANEqwNWAQ_OTMlw_girYd87a_Cvn9nMAgbl-z12vb1zA3j7_Tgdq9Hgzrbe9v2p9Rw97VQf4MWpXqNvH95_Xd5mq88fPy1vVpnmTRUzqGktGg2qBF6kVzHgpC2bRglRUyaMAKOLjrVEEda0tOgaIUCUFQCtdcP5NXo9z12rXm69HZTfS6esvL1ZyUOPUFIJ2lQ7mthiZrV3IXjozgIl8hCF3Mg5CnmIQpJGpiiS9mrWtlM7gDlLf2-fgDczcA-t64K2MGo4YyksXvC0TZ1-VZ3o-v_ppY3Hcy7dNMakvptVSBfdWfDypBvrQUdpnP33Kn8A6tTEDw
CitedBy_id crossref_primary_10_4155_fmc_2021_0109
crossref_primary_10_1016_j_ejmech_2014_11_039
crossref_primary_10_1042_EBC20220046
crossref_primary_10_3762_bjoc_13_276
crossref_primary_10_1002_anie_202309958
crossref_primary_10_1002_elps_201500329
crossref_primary_10_4155_fmc_2017_0026
crossref_primary_10_1002_bip_22670
crossref_primary_10_1016_j_bmc_2017_05_027
crossref_primary_10_1039_C5CC05264E
crossref_primary_10_1016_j_ejmech_2014_10_004
crossref_primary_10_1021_acsnano_7b01662
crossref_primary_10_1016_j_cbpa_2019_07_008
crossref_primary_10_1021_acscombsci_6b00116
crossref_primary_10_1016_j_talanta_2016_12_011
crossref_primary_10_1021_acschemneuro_8b00341
crossref_primary_10_1002_ange_202309958
crossref_primary_10_1002_ejoc_201700010
crossref_primary_10_1002_pep2_24083
crossref_primary_10_1021_acsami_1c02356
crossref_primary_10_1021_acschemneuro_8b00185
crossref_primary_10_1002_cplu_201600550
crossref_primary_10_1002_tcr_202000103
crossref_primary_10_1021_acs_jmedchem_5b01629
Cites_doi 10.4155/FMC.12.94
10.1038/nsmb.1799
10.1016/j.tetasy.2007.08.004
10.1074/jbc.M110.181313
10.1002/cmdc.200700140
10.1021/ar8000475
10.1016/j.drudis.2009.10.009
10.1021/ja107675n
10.1074/jbc.M201750200
10.1016/j.abb.2010.02.001
10.1371/journal.pone.0047261
10.1073/pnas.1218402110
10.1038/nm1782
10.1002/cbic.200900666
10.1073/pnas.0905127106
10.1073/pnas.0506723102
10.1021/ml4002908
10.1038/nrm2101
10.1002/cmdc.201100585
10.1021/bi802046n
10.1517/13543776.2013.772983
10.1021/bi700411k
10.1021/jp408579v
10.1126/science.1213151
10.1016/j.jmb.2011.12.062
10.1016/j.ejmech.2011.10.008
10.1074/jbc.M803159200
10.1038/nchembio.719
10.1016/j.jmb.2013.02.005
10.1126/science.1132814
10.1002/elps.200406062
10.1016/S0076-6879(99)09020-5
10.4155/fmc.12.94
10.1002/1521-3765(20021004)8:19<4365::AID-CHEM4365>3.0.CO;2-U
10.1002/elps.201400271
10.1038/461895a
10.2174/1874070701105010039
10.1002/1521-3773(20020118)41:2<230::AID-ANIE230>3.0.CO;2-L
ContentType Journal Article
Copyright 2014 Elsevier Masson SAS
Copyright © 2014 Elsevier Masson SAS. All rights reserved.
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: 2014 Elsevier Masson SAS
– notice: Copyright © 2014 Elsevier Masson SAS. All rights reserved.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID 1KM
BLEPL
DTL
GNMZZ
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
1XC
DOI 10.1016/j.ejmech.2014.09.031
DatabaseName Index Chemicus
Web of Science Core Collection
Science Citation Index Expanded
Web of Science - Science Citation Index Expanded - 2014
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Hyper Article en Ligne (HAL)
DatabaseTitle Web of Science
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList
MEDLINE
Web of Science

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 1KM
  name: Index Chemicus
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC
  sourceTypes:
    Enrichment Source
    Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1768-3254
EndPage 758
ExternalDocumentID oai_HAL_hal_01067196v1
10_1016_j_ejmech_2014_09_031
25238173
000343781800068
S0223523414008496
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Ministere de l'Enseignement Superieur et de la Recherche (MESR); Ministry of Research, France
GroupedDBID ---
--K
--M
.~1
0R~
1RT
1~.
1~5
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
9JN
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARLI
AATCM
AAXUO
ABFRF
ABGSF
ABJNI
ABMAC
ABOCM
ABUDA
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACIUM
ACRLP
ADBBV
ADECG
ADEZE
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJSZI
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FLBIZ
FNPLU
FYGXN
G-Q
GBLVA
J1W
KOM
M2Y
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SCC
SDF
SDG
SES
SPC
SPCBC
SSK
SSP
SSU
SSZ
T5K
~G-
1KM
AAXKI
AKRWK
BLEPL
DTL
GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED
CGR
CUY
CVF
ECM
EIF
NPM
1B1
29G
AAQXK
AAYOK
AAYXX
ABFNM
ACNNM
ADMUD
AFJKZ
AGRDE
ASPBG
AVWKF
AZFZN
CITATION
FEDTE
FGOYB
G-2
HMS
HMT
HVGLF
HZ~
IHE
R2-
SCB
SEW
SOC
SPT
WUQ
1XC
ID FETCH-LOGICAL-c396t-e81879cea5e345e362e30b599a778127d7edc4f2b0a029b14f977e756ee18c933
IEDL.DBID AIKHN
ISICitedReferencesCount 23
ISICitedReferencesURI https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000343781800068
ISSN 0223-5234
IngestDate Tue Oct 15 15:48:08 EDT 2024
Thu Sep 26 18:17:27 EDT 2024
Sat Sep 28 08:15:34 EDT 2024
Fri Nov 01 20:18:21 EDT 2024
Wed Sep 18 05:37:37 EDT 2024
Fri Feb 23 02:29:18 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords Oligomers
Peptidomimetics
Capillary electrophoresis
Alzheimer's disease
Glycopeptides
Amyloid β-peptide
DESIGN
MIMETICS
ACIDS
STRATEGIES
Amyloid beta-peptide
INHIBITION
SECONDARY NUCLEATION
AGGREGATION
Language English
License Copyright © 2014 Elsevier Masson SAS. All rights reserved.
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
LogoURL https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg
MergedId FETCHMERGED-LOGICAL-c396t-e81879cea5e345e362e30b599a778127d7edc4f2b0a029b14f977e756ee18c933
ORCID 0000-0002-2042-9942
0000-0002-2118-7324
0000-0003-4877-258X
PMID 25238173
PageCount 7
ParticipantIDs webofscience_primary_000343781800068
pubmed_primary_25238173
hal_primary_oai_HAL_hal_01067196v1
elsevier_sciencedirect_doi_10_1016_j_ejmech_2014_09_031
crossref_primary_10_1016_j_ejmech_2014_09_031
webofscience_primary_000343781800068CitationCount
PublicationCentury 2000
PublicationDate 2014-10-30
PublicationDateYYYYMMDD 2014-10-30
PublicationDate_xml – month: 10
  year: 2014
  text: 2014-10-30
  day: 30
PublicationDecade 2010
PublicationPlace ISSY-LES-MOULINEAUX
PublicationPlace_xml – name: ISSY-LES-MOULINEAUX
– name: France
PublicationTitle European journal of medicinal chemistry
PublicationTitleAbbrev EUR J MED CHEM
PublicationTitleAlternate Eur J Med Chem
PublicationYear 2014
Publisher Elsevier Masson SAS
Elsevier
Publisher_xml – name: Elsevier Masson SAS
– name: Elsevier
References Laganowsky, Liu, Sawaya, Whitelegge, Park, Zhao (bib7) 2012; 335
Reference 18.
Härd, Lendel (bib16) 2012; 421
For a review, see
Jan, Gokce, Luthi-Carter, Lashuel (bib11) 2008; 283
Yu, Edalji, Harlan, Holzman, Pereda Lopez, Labkovsky, Hillen, Barghorn, Ebert, Richardson, Miesbauer, Solomon, Bartley, Walter, Johnson, Hajduk, Olejniczak (bib8) 2009; 48
Butini, Brindisi, Brogi, Maramai, Guarino, Panico, Saxena, Chauhan, Colombo, Verga, De Lorenzi, Bartolini, Andrisano, Novellino, Campiani, Gemma (bib31) 2013; 4
Dorgeret, Khemtémourian, Correia, Soulier, Lequin, Ongeri (bib25) 2011; 46
Brinet, Kaffy, Oukacine, Glumm, Ongeri, Taverna (bib28) 2014
Cohen, Linse, Luheshi, Hellstrand, White, Rajah, Otzen, Vendruscolo, Dobson, Knowles (bib3) 2013; 110
Jeong, Ansaloni, Mezzenga, Lashuel, Dietler (bib5) 2013; 425
Smith, Cruz, Hochdörffer, März-Berberich, Nagel-Steger, Epple, Meyer-Zaika, Horn, Sticht, Sinha, Bitan, Schrader (bib29) 2013; 117
Ahmed, Davis, Aucoin, Sato, Ahuja, Aimoto, Elliott, Van Nostrand, Smith (bib9) 2010; 17
Dahlgren, Manelli, Blaine Stine, Baker, Krafft, LaDu (bib10) 2002; 277
LeVine (bib27) 1999; 309
Sabella, Quaglia, Lanni, Racchi, Govoni, Caccialanza, Calligaro, Bellotti, De Lorenzi (bib30) 2004; 25
Necula, Breydo, Milton, Rakez, van der Veer, Tone, Glabe (bib22) 2007; 46
Bieschke, Herbst, Wiglenda (bib21) 2012; 8
Vlieghe, Lisowski, Martinez, Khrestchatisky, Albericio, Kruger (bib24) 2010; 15
Ono, Condron, Teplow (bib12) 2009; 106
Cizas, Budvytyte, Morkuniene, Moldovan, Broccio, Lösche, Niaura, Valincius, Borutaite (bib15) 2010; 496
Belluti, Rampa, Gobbi, Bisi (bib20) 2013; 23
Matsumura, Shinoda, Yamada, Yokojima, Inoue, Ohnishi, Shimada, Kikuchi, Masui, Hashimoto, Sato, Ito, Akioka, Takagi, Nakamura, Nemoto, Hasegawa, Takamoto, Inoue, Nakamura, Nabeshima, Teplow, Kinjo, Hoshi (bib4) 2011; 286
Prangkio, Yusko, Sept, Yang, Mayer (bib14) 2012; 7
.
Liu, Bitan (bib19) 2012; 7
Bartolini, Andrisano (bib17) 2010; 11
Gruner, Truffault, Voll, Locardi, Stöckle, Kessler, Schweizer, Risseueuw, Overhand, Fleet, Simone (bib26) 2002; 8
Lührs, Ritter, Adrian, Riek-Loher, Bohrmann, Döbeli, Schubert, Riek (bib6) 2005; 102
Goedert, Spillantini, Haas, Selkoe (bib2) 2006; 314
Stains, Mondal, Ghosh (bib18) 2007; 2
Shankar, Li, Mehta, Garcia-Munoz, Shepardson, Smith, Brett, Farrell, Rowan, Lemere, Regan, Walsh, Sabatini, Selkoe (bib13) 2008; 14
Cohen, SIA (WOS:000320930100045) 2013; 110
Takahashi, T (WOS:000260254300009) 2008; 41
Brinet, D. (000343781800068.6) 2014
Goedert, M (WOS:000241729800034) 2006; 314
Smith, MD (WOS:000328101100003) 2013; 117
Hochdorffer, K (WOS:000291715300041) 2011; 133
Neddenriep, Bradley (MEDLINE:24653784) 2011; 5
Laganowsky, A (WOS:000301225100046) 2012; 335
Bartolini, M (WOS:000278482200001) 2010; 11
Gruner, SAW (WOS:000178542000003) 2002; 8
Ahmed, M (WOS:000277330700008) 2010; 17
Yu, LP (WOS:000263896100004) 2009; 48
Shankar, GM (WOS:000258237500030) 2008; 14
Bieschke, J (WOS:000298414100017) 2012; 8
Jeong, JS (WOS:000319490100014) 2013; 425
Dorgeret, B (WOS:000297874300027) 2011; 46
Butini, S (WOS:000328529400014) 2013; 4
Schweizer, F (WOS:000173523400002) 2002; 41
Albericio, F (WOS:000308959400001) 2012; 4
Necula, M (WOS:000248229800016) 2007; 46
Vlieghe, P (WOS:000274085900006) 2010; 15
Risseeuw, MDP (WOS:000250607100001) 2007; 18
Liu, TY (WOS:000300942300003) 2012; 7
Luhrs, T (WOS:000233762000016) 2005; 102
Matsumura, S (WOS:000288797100065) 2011; 286
Jan, A (WOS:000259969300020) 2008; 283
Prangkio, P (WOS:000309995100083) 2012; 7
Cizas, P (WOS:000276757900003) 2010; 496
Ono, K (WOS:000269481000005) 2009; 106
LeVine, H (WOS:000084721400018) 1999; 309
Sabella, S (WOS:000224649500019) 2004; 25
Hard, T (WOS:000308383800003) 2012; 421
Haass, C (WOS:000243730300012) 2007; 8
Stains, CI (WOS:000251678000001) 2007; 2
Dahlgren, KN (WOS:000177718700093) 2002; 277
Belluti, F (WOS:000317936300004) 2013; 23
Laganowsky (10.1016/j.ejmech.2014.09.031_bib7) 2012; 335
Butini (10.1016/j.ejmech.2014.09.031_bib31) 2013; 4
10.1016/j.ejmech.2014.09.031_bib23a
Bartolini (10.1016/j.ejmech.2014.09.031_bib17) 2010; 11
Jeong (10.1016/j.ejmech.2014.09.031_bib5) 2013; 425
Goedert (10.1016/j.ejmech.2014.09.031_bib2a) 2006; 314
Bieschke (10.1016/j.ejmech.2014.09.031_bib21) 2012; 8
Dahlgren (10.1016/j.ejmech.2014.09.031_bib10) 2002; 277
Smith (10.1016/j.ejmech.2014.09.031_bib29a) 2013; 117
Cizas (10.1016/j.ejmech.2014.09.031_bib15) 2010; 496
Schweizer (10.1016/j.ejmech.2014.09.031_bib26b) 2002; 41
Prangkio (10.1016/j.ejmech.2014.09.031_bib14) 2012; 7
Cohen (10.1016/j.ejmech.2014.09.031_bib3) 2013; 110
Takahashi (10.1016/j.ejmech.2014.09.031_bib23b) 2008; 41
Stains (10.1016/j.ejmech.2014.09.031_bib18) 2007; 2
Shankar (10.1016/j.ejmech.2014.09.031_bib13) 2008; 14
Yu (10.1016/j.ejmech.2014.09.031_bib8) 2009; 48
10.1016/j.ejmech.2014.09.031_oref1
Lührs (10.1016/j.ejmech.2014.09.031_bib6) 2005; 102
Härd (10.1016/j.ejmech.2014.09.031_bib16) 2012; 421
Sabella (10.1016/j.ejmech.2014.09.031_bib30) 2004; 25
Vlieghe (10.1016/j.ejmech.2014.09.031_bib24a) 2010; 15
Ahmed (10.1016/j.ejmech.2014.09.031_bib9) 2010; 17
Necula (10.1016/j.ejmech.2014.09.031_bib22) 2007; 46
Liu (10.1016/j.ejmech.2014.09.031_bib19) 2012; 7
Jan (10.1016/j.ejmech.2014.09.031_bib11) 2008; 283
Brinet (10.1016/j.ejmech.2014.09.031_bib28) 2014
Neddenriep (10.1016/j.ejmech.2014.09.031_bib23c) 2011; 5
LeVine (10.1016/j.ejmech.2014.09.031_bib27) 1999; 309
Dorgeret (10.1016/j.ejmech.2014.09.031_bib25) 2011; 46
Matsumura (10.1016/j.ejmech.2014.09.031_bib4) 2011; 286
Hochdörffer (10.1016/j.ejmech.2014.09.031_bib29b) 2011; 133
Haas (10.1016/j.ejmech.2014.09.031_bib2b) 2007; 8
10.1016/j.ejmech.2014.09.031_bib1a
Belluti (10.1016/j.ejmech.2014.09.031_bib20) 2013; 23
Gruner (10.1016/j.ejmech.2014.09.031_bib26a) 2002; 8
Ono (10.1016/j.ejmech.2014.09.031_bib12) 2009; 106
Mucke (10.1016/j.ejmech.2014.09.031_bib1b) 2009; 461
Risseueuw (10.1016/j.ejmech.2014.09.031_bib26c) 2007; 18
Albericio (10.1016/j.ejmech.2014.09.031_bib24b) 2012; 4
References_xml – volume: 496
  start-page: 84
  year: 2010
  end-page: 92
  ident: bib15
  article-title: Size-dependent neurotoxicity of β-amyloid oligomers
  publication-title: Arch. Biochem. Biophys.
  contributor:
    fullname: Borutaite
– volume: 335
  start-page: 1228
  year: 2012
  end-page: 1231
  ident: bib7
  article-title: Atomic view of a toxic amyloid small oligomer
  publication-title: Science
  contributor:
    fullname: Zhao
– year: 2014
  ident: bib28
  article-title: An improved CE method for the in vitro monitoring of the challenging early steps of the Aβ
  publication-title: Electrophoresis
  contributor:
    fullname: Taverna
– volume: 4
  start-page: 1178
  year: 2013
  end-page: 1182
  ident: bib31
  publication-title: ACS Med. Chem. Lett.
  contributor:
    fullname: Gemma
– volume: 7
  start-page: 359
  year: 2012
  end-page: 374
  ident: bib19
  article-title: Modulating self-assembly amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanism
  publication-title: ChemMedChem
  contributor:
    fullname: Bitan
– volume: 425
  start-page: 1765
  year: 2013
  end-page: 1781
  ident: bib5
  article-title: Novel mechanistic insight into the molecular basis of amyloid polymorphism and secondary nucleation during amyloid formation
  publication-title: J. Mol. Biol.
  contributor:
    fullname: Dietler
– volume: 283
  start-page: 28176
  year: 2008
  end-page: 28189
  ident: bib11
  article-title: The ratio of monomeric to aggregated forms of Aβ40 and Aβ42 is an important determinant of amyloid-β aggregation, fibrillogenesis, and toxicity
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Lashuel
– volume: 8
  start-page: 93
  year: 2012
  end-page: 101
  ident: bib21
  article-title: Small-molecule conversion of toxic oligomerts to nontoxic β-sheet-rich amyloid fibrils
  publication-title: Nat. Chem. Biol.
  contributor:
    fullname: Wiglenda
– volume: 15
  start-page: 40
  year: 2010
  end-page: 56
  ident: bib24
  article-title: Synthetic therapeutic peptides: science and market
  publication-title: Drug Discov. Today
  contributor:
    fullname: Kruger
– volume: 110
  start-page: 9758
  year: 2013
  end-page: 9763
  ident: bib3
  article-title: Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Knowles
– volume: 117
  start-page: 14907
  year: 2013
  end-page: 14915
  ident: bib29
  article-title: Changes to the structure and dynamics in mutations of Aβ
  publication-title: J. Phys. Chem. B
  contributor:
    fullname: Schrader
– volume: 46
  start-page: 8850
  year: 2007
  end-page: 8860
  ident: bib22
  article-title: Methylene blue inhibits amyloid Aβ oligomerization by promoting fibrillization
  publication-title: Biochemistry
  contributor:
    fullname: Glabe
– volume: 277
  start-page: 32046
  year: 2002
  end-page: 32053
  ident: bib10
  article-title: Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
  publication-title: J. Biol. Chem.
  contributor:
    fullname: LaDu
– volume: 421
  start-page: 441
  year: 2012
  end-page: 465
  ident: bib16
  article-title: Inhibition of amyloid formation
  publication-title: J. Mol. Biol.
  contributor:
    fullname: Lendel
– volume: 23
  start-page: 581
  year: 2013
  end-page: 596
  ident: bib20
  article-title: Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010–2012)
  publication-title: Expert Opin. Ther. Pat.
  contributor:
    fullname: Bisi
– volume: 8
  start-page: 4366
  year: 2002
  end-page: 4376
  ident: bib26
  article-title: Design, synthesis, and NMR structure of linear and cyclic oligomers containing novel furanoid sugar amino acids
  publication-title: Chem. Eur. J.
  contributor:
    fullname: Simone
– volume: 314
  start-page: 777
  year: 2006
  end-page: 780
  ident: bib2
  article-title: A century of Alzheimer's disease
  publication-title: Science
  contributor:
    fullname: Selkoe
– volume: 11
  start-page: 1018
  year: 2010
  end-page: 1035
  ident: bib17
  article-title: Strategies for the inhibition of protein aggregation in human diseases
  publication-title: ChemBioChem
  contributor:
    fullname: Andrisano
– volume: 7
  start-page: e47261
  year: 2012
  ident: bib14
  article-title: Multivariate analyses of amyloid-beta oligomer populations indicate a connection between pore formation and cytotoxicity
  publication-title: PLoS One
  contributor:
    fullname: Mayer
– volume: 46
  start-page: 5959
  year: 2011
  end-page: 5969
  ident: bib25
  article-title: Sugar-based peptidomimetics inhibit amyloid β-peptide aggregation
  publication-title: Eur. J. Med. Chem.
  contributor:
    fullname: Ongeri
– volume: 106
  start-page: 14745
  year: 2009
  end-page: 14750
  ident: bib12
  article-title: Structure–neurotoxicity relationships of amyloid β-protein oligomers
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Teplow
– volume: 286
  start-page: 11555
  year: 2011
  end-page: 11562
  ident: bib4
  article-title: Two distinct amyloid β-protein (Aβ) assembly pathways leading to oligomers and fibrils identified by combined fluorescence correlation spectroscopy, morphology, and toxicity analyses
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Hoshi
– volume: 17
  start-page: 561
  year: 2010
  end-page: 567
  ident: bib9
  article-title: Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils
  publication-title: Nat. Struct. Mol. Biol.
  contributor:
    fullname: Smith
– volume: 2
  start-page: 1674
  year: 2007
  end-page: 1692
  ident: bib18
  article-title: Molecules that target beta-amyloid
  publication-title: ChemMedChem
  contributor:
    fullname: Ghosh
– volume: 309
  start-page: 274
  year: 1999
  end-page: 284
  ident: bib27
  article-title: Quantification of β-sheet amyloid fibril structures with thioflavin T
  publication-title: Methods Enzymol.
  contributor:
    fullname: LeVine
– volume: 48
  start-page: 1870
  year: 2009
  end-page: 1877
  ident: bib8
  article-title: Structural characterization of a soluble amyloid β-peptide oligomer
  publication-title: Biochemistry
  contributor:
    fullname: Olejniczak
– volume: 14
  start-page: 837
  year: 2008
  end-page: 842
  ident: bib13
  article-title: Amyloid β-protein dimers isolated directly from Alzheimer brains impair synaptic plasticity and memory
  publication-title: Nat. Med.
  contributor:
    fullname: Selkoe
– volume: 102
  start-page: 17342
  year: 2005
  end-page: 17347
  ident: bib6
  article-title: 3D structure of Alzheimer's amyloid-β(1–42) fibrils
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Riek
– volume: 25
  start-page: 3186
  year: 2004
  end-page: 3194
  ident: bib30
  article-title: Capillary electrophoresis studies on the aggregation process of β-amyloid 1–42 and 1–40 peptides
  publication-title: Electrophoresis
  contributor:
    fullname: De Lorenzi
– volume: 5
  start-page: 39
  year: 2011
  ident: MEDLINE:24653784
  article-title: Short Peptides as Inhibitors of Amyloid Aggregation.
  publication-title: The open biotechnology journal
  contributor:
    fullname: Neddenriep, Bradley
– year: 2014
  ident: 000343781800068.6
  article-title: An improved CE method for the in vitro monitoring of the challenging early steps of the Aβ1-42Peptide oligomerization: application to anti-Alzheimer's drug discovery
  publication-title: Electrophoresis
  contributor:
    fullname: Brinet, D.
– volume: 4
  start-page: 1527
  year: 2012
  ident: WOS:000308959400001
  article-title: Therapeutic peptides FOREWORD
  publication-title: FUTURE MEDICINAL CHEMISTRY
  doi: 10.4155/FMC.12.94
  contributor:
    fullname: Albericio, F
– volume: 17
  start-page: 561
  year: 2010
  ident: WOS:000277330700008
  article-title: Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils
  publication-title: NATURE STRUCTURAL & MOLECULAR BIOLOGY
  doi: 10.1038/nsmb.1799
  contributor:
    fullname: Ahmed, M
– volume: 18
  start-page: 2001
  year: 2007
  ident: WOS:000250607100001
  article-title: A compendium of sugar amino acids (SAA): scaffolds, peptide- and glyco-mimetics
  publication-title: TETRAHEDRON-ASYMMETRY
  doi: 10.1016/j.tetasy.2007.08.004
  contributor:
    fullname: Risseeuw, MDP
– volume: 286
  start-page: 11555
  year: 2011
  ident: WOS:000288797100065
  article-title: Two Distinct Amyloid beta-Protein (A beta) Assembly Pathways Leading to Oligomers and Fibrils Identified by Combined Fluorescence Correlation Spectroscopy, Morphology, and Toxicity Analyses
  publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY
  doi: 10.1074/jbc.M110.181313
  contributor:
    fullname: Matsumura, S
– volume: 2
  start-page: 1674
  year: 2007
  ident: WOS:000251678000001
  article-title: Molecules that target beta-amyloid
  publication-title: CHEMMEDCHEM
  doi: 10.1002/cmdc.200700140
  contributor:
    fullname: Stains, CI
– volume: 41
  start-page: 1309
  year: 2008
  ident: WOS:000260254300009
  article-title: Peptide and Protein Mimetics Inhibiting Amyloid beta-Peptide Aggregation
  publication-title: ACCOUNTS OF CHEMICAL RESEARCH
  doi: 10.1021/ar8000475
  contributor:
    fullname: Takahashi, T
– volume: 15
  start-page: 40
  year: 2010
  ident: WOS:000274085900006
  article-title: Synthetic therapeutic peptides: science and market
  publication-title: DRUG DISCOVERY TODAY
  doi: 10.1016/j.drudis.2009.10.009
  contributor:
    fullname: Vlieghe, P
– volume: 133
  start-page: 4348
  year: 2011
  ident: WOS:000291715300041
  article-title: Rational Design of beta-Sheet Ligands Against A beta(42)-Induced Toxicity
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/ja107675n
  contributor:
    fullname: Hochdorffer, K
– volume: 277
  start-page: 32046
  year: 2002
  ident: WOS:000177718700093
  article-title: Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability
  publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY
  doi: 10.1074/jbc.M201750200
  contributor:
    fullname: Dahlgren, KN
– volume: 496
  start-page: 84
  year: 2010
  ident: WOS:000276757900003
  article-title: Size-dependent neurotoxicity of beta-amyloid oligomers
  publication-title: ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
  doi: 10.1016/j.abb.2010.02.001
  contributor:
    fullname: Cizas, P
– volume: 7
  start-page: ARTN e47261
  year: 2012
  ident: WOS:000309995100083
  article-title: Multivariate Analyses of Amyloid-Beta Oligomer Populations Indicate a Connection between Pore Formation and Cytotoxicity
  publication-title: PLOS ONE
  doi: 10.1371/journal.pone.0047261
  contributor:
    fullname: Prangkio, P
– volume: 110
  start-page: 9758
  year: 2013
  ident: WOS:000320930100045
  article-title: Proliferation of amyloid-beta 42 aggregates occurs through a secondary nucleation mechanism
  publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
  doi: 10.1073/pnas.1218402110
  contributor:
    fullname: Cohen, SIA
– volume: 14
  start-page: 837
  year: 2008
  ident: WOS:000258237500030
  article-title: Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
  publication-title: NATURE MEDICINE
  doi: 10.1038/nm1782
  contributor:
    fullname: Shankar, GM
– volume: 41
  start-page: 230
  year: 2002
  ident: WOS:000173523400002
  article-title: Glycosamino acids: Building blocks for combinatorial synthesis - Implications for drug discovery
  publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
  contributor:
    fullname: Schweizer, F
– volume: 11
  start-page: 1018
  year: 2010
  ident: WOS:000278482200001
  article-title: Strategies for the Inhibition of Protein Aggregation in Human Diseases
  publication-title: CHEMBIOCHEM
  doi: 10.1002/cbic.200900666
  contributor:
    fullname: Bartolini, M
– volume: 106
  start-page: 14745
  year: 2009
  ident: WOS:000269481000005
  article-title: Structure-neurotoxicity relationships of amyloid beta-protein oligomers
  publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
  doi: 10.1073/pnas.0905127106
  contributor:
    fullname: Ono, K
– volume: 102
  start-page: 17342
  year: 2005
  ident: WOS:000233762000016
  article-title: 3D structure of Alzheimer's amyloid-beta(1-42) fibrils
  publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
  doi: 10.1073/pnas.0506723102
  contributor:
    fullname: Luhrs, T
– volume: 4
  start-page: 1178
  year: 2013
  ident: WOS:000328529400014
  article-title: Multifunctional Cholinesterase and Amyloid Beta Fibrillization Modulators. Synthesis and Biological Investigation
  publication-title: ACS MEDICINAL CHEMISTRY LETTERS
  doi: 10.1021/ml4002908
  contributor:
    fullname: Butini, S
– volume: 8
  start-page: 101
  year: 2007
  ident: WOS:000243730300012
  article-title: Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide
  publication-title: NATURE REVIEWS MOLECULAR CELL BIOLOGY
  doi: 10.1038/nrm2101
  contributor:
    fullname: Haass, C
– volume: 7
  start-page: 359
  year: 2012
  ident: WOS:000300942300003
  article-title: Modulating Self-Assembly of Amyloidogenic Proteins as a Therapeutic Approach for Neurodegenerative Diseases: Strategies and Mechanisms
  publication-title: CHEMMEDCHEM
  doi: 10.1002/cmdc.201100585
  contributor:
    fullname: Liu, TY
– volume: 48
  start-page: 1870
  year: 2009
  ident: WOS:000263896100004
  article-title: Structural Characterization of a Soluble Amyloid beta-Peptide Oligomer
  publication-title: BIOCHEMISTRY
  doi: 10.1021/bi802046n
  contributor:
    fullname: Yu, LP
– volume: 23
  start-page: 581
  year: 2013
  ident: WOS:000317936300004
  article-title: Small-molecule inhibitors/modulators of amyloid-beta peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010-2012)
  publication-title: EXPERT OPINION ON THERAPEUTIC PATENTS
  doi: 10.1517/13543776.2013.772983
  contributor:
    fullname: Belluti, F
– volume: 46
  start-page: 8850
  year: 2007
  ident: WOS:000248229800016
  article-title: Methylene blue inhibits amyloid A beta oligomerization by promoting fibrillization
  publication-title: BIOCHEMISTRY
  doi: 10.1021/bi700411k
  contributor:
    fullname: Necula, M
– volume: 117
  start-page: 14907
  year: 2013
  ident: WOS:000328101100003
  article-title: Changes to the Structure and Dynamics in Mutations of A beta(21-30) Caused by Ions in Solution
  publication-title: JOURNAL OF PHYSICAL CHEMISTRY B
  doi: 10.1021/jp408579v
  contributor:
    fullname: Smith, MD
– volume: 8
  start-page: 4366
  year: 2002
  ident: WOS:000178542000003
  article-title: Design, synthesis, and NMR structure of linear and cyclic oligomers containing novel furanoid sugar amino acids
  publication-title: CHEMISTRY-A EUROPEAN JOURNAL
  contributor:
    fullname: Gruner, SAW
– volume: 309
  start-page: 274
  year: 1999
  ident: WOS:000084721400018
  article-title: Quantification of beta-sheet amyloid fibril structures with thioflavin T
  publication-title: AMYLOID, PRIONS, AND OTHER PROTEIN AGGREGATES
  contributor:
    fullname: LeVine, H
– volume: 335
  start-page: 1228
  year: 2012
  ident: WOS:000301225100046
  article-title: Atomic View of a Toxic Amyloid Small Oligomer
  publication-title: SCIENCE
  doi: 10.1126/science.1213151
  contributor:
    fullname: Laganowsky, A
– volume: 421
  start-page: 441
  year: 2012
  ident: WOS:000308383800003
  article-title: Inhibition of Amyloid Formation
  publication-title: JOURNAL OF MOLECULAR BIOLOGY
  doi: 10.1016/j.jmb.2011.12.062
  contributor:
    fullname: Hard, T
– volume: 46
  start-page: 5959
  year: 2011
  ident: WOS:000297874300027
  article-title: Sugar-based peptidomimetics inhibit amyloid beta-peptide aggregation
  publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1016/j.ejmech.2011.10.008
  contributor:
    fullname: Dorgeret, B
– volume: 283
  start-page: 28176
  year: 2008
  ident: WOS:000259969300020
  article-title: The ratio of monomeric to aggregated forms of A beta 40 and A beta 42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity
  publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY
  doi: 10.1074/jbc.M803159200
  contributor:
    fullname: Jan, A
– volume: 8
  start-page: 93
  year: 2012
  ident: WOS:000298414100017
  article-title: Small-molecule conversion of toxic oligomers to nontoxic beta-sheet-rich amyloid fibrils
  publication-title: NATURE CHEMICAL BIOLOGY
  doi: 10.1038/nchembio.719
  contributor:
    fullname: Bieschke, J
– volume: 425
  start-page: 1765
  year: 2013
  ident: WOS:000319490100014
  article-title: Novel Mechanistic Insight into the Molecular Basis of Amyloid Polymorphism and Secondary Nucleation during Amyloid Formation
  publication-title: JOURNAL OF MOLECULAR BIOLOGY
  doi: 10.1016/j.jmb.2013.02.005
  contributor:
    fullname: Jeong, JS
– volume: 314
  start-page: 777
  year: 2006
  ident: WOS:000241729800034
  article-title: A century of Alzheimer's disease
  publication-title: SCIENCE
  doi: 10.1126/science.1132814
  contributor:
    fullname: Goedert, M
– volume: 25
  start-page: 3186
  year: 2004
  ident: WOS:000224649500019
  article-title: Capillary electrophoresis studies on the aggregation process of beta-amyloid 1-42 and 1-40 peptides
  publication-title: ELECTROPHORESIS
  doi: 10.1002/elps.200406062
  contributor:
    fullname: Sabella, S
– volume: 283
  start-page: 28176
  year: 2008
  ident: 10.1016/j.ejmech.2014.09.031_bib11
  article-title: The ratio of monomeric to aggregated forms of Aβ40 and Aβ42 is an important determinant of amyloid-β aggregation, fibrillogenesis, and toxicity
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M803159200
  contributor:
    fullname: Jan
– volume: 48
  start-page: 1870
  year: 2009
  ident: 10.1016/j.ejmech.2014.09.031_bib8
  article-title: Structural characterization of a soluble amyloid β-peptide oligomer
  publication-title: Biochemistry
  doi: 10.1021/bi802046n
  contributor:
    fullname: Yu
– ident: 10.1016/j.ejmech.2014.09.031_oref1
– volume: 46
  start-page: 5959
  year: 2011
  ident: 10.1016/j.ejmech.2014.09.031_bib25
  article-title: Sugar-based peptidomimetics inhibit amyloid β-peptide aggregation
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2011.10.008
  contributor:
    fullname: Dorgeret
– volume: 110
  start-page: 9758
  year: 2013
  ident: 10.1016/j.ejmech.2014.09.031_bib3
  article-title: Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1218402110
  contributor:
    fullname: Cohen
– volume: 11
  start-page: 1018
  year: 2010
  ident: 10.1016/j.ejmech.2014.09.031_bib17
  article-title: Strategies for the inhibition of protein aggregation in human diseases
  publication-title: ChemBioChem
  doi: 10.1002/cbic.200900666
  contributor:
    fullname: Bartolini
– volume: 25
  start-page: 3186
  year: 2004
  ident: 10.1016/j.ejmech.2014.09.031_bib30
  article-title: Capillary electrophoresis studies on the aggregation process of β-amyloid 1–42 and 1–40 peptides
  publication-title: Electrophoresis
  doi: 10.1002/elps.200406062
  contributor:
    fullname: Sabella
– ident: 10.1016/j.ejmech.2014.09.031_bib1a
– volume: 15
  start-page: 40
  year: 2010
  ident: 10.1016/j.ejmech.2014.09.031_bib24a
  article-title: Synthetic therapeutic peptides: science and market
  publication-title: Drug Discov. Today
  doi: 10.1016/j.drudis.2009.10.009
  contributor:
    fullname: Vlieghe
– volume: 309
  start-page: 274
  year: 1999
  ident: 10.1016/j.ejmech.2014.09.031_bib27
  article-title: Quantification of β-sheet amyloid fibril structures with thioflavin T
  publication-title: Methods Enzymol.
  doi: 10.1016/S0076-6879(99)09020-5
  contributor:
    fullname: LeVine
– volume: 7
  start-page: 359
  year: 2012
  ident: 10.1016/j.ejmech.2014.09.031_bib19
  article-title: Modulating self-assembly amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanism
  publication-title: ChemMedChem
  doi: 10.1002/cmdc.201100585
  contributor:
    fullname: Liu
– volume: 133
  start-page: 4348
  year: 2011
  ident: 10.1016/j.ejmech.2014.09.031_bib29b
  article-title: Rational design of β-sheet ligands against Aβ42-induced toxicity
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja107675n
  contributor:
    fullname: Hochdörffer
– volume: 286
  start-page: 11555
  year: 2011
  ident: 10.1016/j.ejmech.2014.09.031_bib4
  article-title: Two distinct amyloid β-protein (Aβ) assembly pathways leading to oligomers and fibrils identified by combined fluorescence correlation spectroscopy, morphology, and toxicity analyses
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M110.181313
  contributor:
    fullname: Matsumura
– volume: 4
  start-page: 1527
  year: 2012
  ident: 10.1016/j.ejmech.2014.09.031_bib24b
  article-title: Therapeutic peptides
  publication-title: Future Med. Chem.
  doi: 10.4155/fmc.12.94
  contributor:
    fullname: Albericio
– volume: 4
  start-page: 1178
  year: 2013
  ident: 10.1016/j.ejmech.2014.09.031_bib31
  publication-title: ACS Med. Chem. Lett.
  doi: 10.1021/ml4002908
  contributor:
    fullname: Butini
– volume: 2
  start-page: 1674
  year: 2007
  ident: 10.1016/j.ejmech.2014.09.031_bib18
  article-title: Molecules that target beta-amyloid
  publication-title: ChemMedChem
  doi: 10.1002/cmdc.200700140
  contributor:
    fullname: Stains
– volume: 23
  start-page: 581
  year: 2013
  ident: 10.1016/j.ejmech.2014.09.031_bib20
  article-title: Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010–2012)
  publication-title: Expert Opin. Ther. Pat.
  doi: 10.1517/13543776.2013.772983
  contributor:
    fullname: Belluti
– ident: 10.1016/j.ejmech.2014.09.031_bib23a
– volume: 46
  start-page: 8850
  year: 2007
  ident: 10.1016/j.ejmech.2014.09.031_bib22
  article-title: Methylene blue inhibits amyloid Aβ oligomerization by promoting fibrillization
  publication-title: Biochemistry
  doi: 10.1021/bi700411k
  contributor:
    fullname: Necula
– volume: 8
  start-page: 4366
  year: 2002
  ident: 10.1016/j.ejmech.2014.09.031_bib26a
  article-title: Design, synthesis, and NMR structure of linear and cyclic oligomers containing novel furanoid sugar amino acids
  publication-title: Chem. Eur. J.
  doi: 10.1002/1521-3765(20021004)8:19<4365::AID-CHEM4365>3.0.CO;2-U
  contributor:
    fullname: Gruner
– volume: 14
  start-page: 837
  year: 2008
  ident: 10.1016/j.ejmech.2014.09.031_bib13
  article-title: Amyloid β-protein dimers isolated directly from Alzheimer brains impair synaptic plasticity and memory
  publication-title: Nat. Med.
  doi: 10.1038/nm1782
  contributor:
    fullname: Shankar
– volume: 335
  start-page: 1228
  year: 2012
  ident: 10.1016/j.ejmech.2014.09.031_bib7
  article-title: Atomic view of a toxic amyloid small oligomer
  publication-title: Science
  doi: 10.1126/science.1213151
  contributor:
    fullname: Laganowsky
– year: 2014
  ident: 10.1016/j.ejmech.2014.09.031_bib28
  article-title: An improved CE method for the in vitro monitoring of the challenging early steps of the Aβ1–42 peptide oligomerization: application to anti-Alzheimer's drug discovery
  publication-title: Electrophoresis
  doi: 10.1002/elps.201400271
  contributor:
    fullname: Brinet
– volume: 8
  start-page: 93
  year: 2012
  ident: 10.1016/j.ejmech.2014.09.031_bib21
  article-title: Small-molecule conversion of toxic oligomerts to nontoxic β-sheet-rich amyloid fibrils
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/nchembio.719
  contributor:
    fullname: Bieschke
– volume: 8
  start-page: 101
  year: 2007
  ident: 10.1016/j.ejmech.2014.09.031_bib2b
  article-title: Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer amyloid β-peptide
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm2101
  contributor:
    fullname: Haas
– volume: 102
  start-page: 17342
  year: 2005
  ident: 10.1016/j.ejmech.2014.09.031_bib6
  article-title: 3D structure of Alzheimer's amyloid-β(1–42) fibrils
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0506723102
  contributor:
    fullname: Lührs
– volume: 41
  start-page: 1309
  year: 2008
  ident: 10.1016/j.ejmech.2014.09.031_bib23b
  article-title: Peptide and protein mimetics inhibiting amyloid peptide aggregation
  publication-title: Acc. Chem. Res.
  doi: 10.1021/ar8000475
  contributor:
    fullname: Takahashi
– volume: 117
  start-page: 14907
  year: 2013
  ident: 10.1016/j.ejmech.2014.09.031_bib29a
  article-title: Changes to the structure and dynamics in mutations of Aβ21–30 caused by ions in solution
  publication-title: J. Phys. Chem. B
  doi: 10.1021/jp408579v
  contributor:
    fullname: Smith
– volume: 277
  start-page: 32046
  year: 2002
  ident: 10.1016/j.ejmech.2014.09.031_bib10
  article-title: Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M201750200
  contributor:
    fullname: Dahlgren
– volume: 18
  start-page: 2001
  year: 2007
  ident: 10.1016/j.ejmech.2014.09.031_bib26c
  article-title: A compendium of sugar amino acids (SAA): scaffolds, peptide- and glyco-mimetics
  publication-title: Tetrahedron Asymmetry
  doi: 10.1016/j.tetasy.2007.08.004
  contributor:
    fullname: Risseueuw
– volume: 421
  start-page: 441
  year: 2012
  ident: 10.1016/j.ejmech.2014.09.031_bib16
  article-title: Inhibition of amyloid formation
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2011.12.062
  contributor:
    fullname: Härd
– volume: 496
  start-page: 84
  year: 2010
  ident: 10.1016/j.ejmech.2014.09.031_bib15
  article-title: Size-dependent neurotoxicity of β-amyloid oligomers
  publication-title: Arch. Biochem. Biophys.
  doi: 10.1016/j.abb.2010.02.001
  contributor:
    fullname: Cizas
– volume: 461
  start-page: 895
  year: 2009
  ident: 10.1016/j.ejmech.2014.09.031_bib1b
  article-title: Alzheimers's disease
  publication-title: Nature
  doi: 10.1038/461895a
  contributor:
    fullname: Mucke
– volume: 106
  start-page: 14745
  year: 2009
  ident: 10.1016/j.ejmech.2014.09.031_bib12
  article-title: Structure–neurotoxicity relationships of amyloid β-protein oligomers
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0905127106
  contributor:
    fullname: Ono
– volume: 17
  start-page: 561
  year: 2010
  ident: 10.1016/j.ejmech.2014.09.031_bib9
  article-title: Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils
  publication-title: Nat. Struct. Mol. Biol.
  doi: 10.1038/nsmb.1799
  contributor:
    fullname: Ahmed
– volume: 7
  start-page: e47261
  year: 2012
  ident: 10.1016/j.ejmech.2014.09.031_bib14
  article-title: Multivariate analyses of amyloid-beta oligomer populations indicate a connection between pore formation and cytotoxicity
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0047261
  contributor:
    fullname: Prangkio
– volume: 5
  start-page: 39
  year: 2011
  ident: 10.1016/j.ejmech.2014.09.031_bib23c
  article-title: Short peptides as inhibitors of amyloid aggregation
  publication-title: Open Biotechnol. J.
  doi: 10.2174/1874070701105010039
  contributor:
    fullname: Neddenriep
– volume: 425
  start-page: 1765
  year: 2013
  ident: 10.1016/j.ejmech.2014.09.031_bib5
  article-title: Novel mechanistic insight into the molecular basis of amyloid polymorphism and secondary nucleation during amyloid formation
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2013.02.005
  contributor:
    fullname: Jeong
– volume: 314
  start-page: 777
  year: 2006
  ident: 10.1016/j.ejmech.2014.09.031_bib2a
  article-title: A century of Alzheimer's disease
  publication-title: Science
  doi: 10.1126/science.1132814
  contributor:
    fullname: Goedert
– volume: 41
  start-page: 230
  year: 2002
  ident: 10.1016/j.ejmech.2014.09.031_bib26b
  article-title: Glycosamino acids: building blocks for combinatorial synthesis–implications for drug discovery
  publication-title: Angew. Chem. Int. Ed.
  doi: 10.1002/1521-3773(20020118)41:2<230::AID-ANIE230>3.0.CO;2-L
  contributor:
    fullname: Schweizer
SSID ssj0005600
Score 2.2813416
Snippet Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid β peptides. Aβ1–42 being the most aggregative and...
Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid beta peptides. A beta(1-42) being the most...
Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid β peptides. Aβ1-42 being the most aggregative and...
: Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid β peptides. Aβ1-42 being the most aggregative and...
Source Web of Science
SourceID hal
crossref
pubmed
webofscience
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 752
SubjectTerms Alzheimer's disease
Amyloid beta-Peptides - chemistry
Amyloid beta-Peptides - drug effects
Amyloid β-peptide
Capillary electrophoresis
Carbohydrates - chemistry
Chemical Sciences
Chemistry, Medicinal
Glycopeptides
Life Sciences & Biomedicine
Oligomers
Oligopeptides - chemistry
Oligopeptides - drug effects
Organic chemistry
Peptide Fragments - chemistry
Peptide Fragments - drug effects
Peptidomimetics
Peptidomimetics - chemistry
Peptidomimetics - pharmacology
Pharmacology & Pharmacy
Protein Multimerization - drug effects
Science & Technology
Structure-Activity Relationship
Title Structure–activity relationships of sugar-based peptidomimetics as modulators of amyloid β-peptide early oligomerization and fibrillization
URI https://dx.doi.org/10.1016/j.ejmech.2014.09.031
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000343781800068
https://www.ncbi.nlm.nih.gov/pubmed/25238173
https://hal.science/hal-01067196
Volume 86
WOS 000343781800068
WOSCitedRecordID wos000343781800068
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswEB3EzqG9FG26uUtAFEFOUS2JkhgeDaOBuwUBkgC5EZQ4ShRYlmE5BXwp-gW99E_6If2Ifkk5lGS3hy7oQQdRI2gZat4InPcGYM9YSNEhT53yoxdlAfd0jsaTfqQzaRE7N_Sj-P44mZxHby7iiy0Yd1wYKqtsY38T0120bkeG7dsczotieGrRx2YPNgpHJAovkx5su0WiPmyPXr-dHG8qPZKGiWLt6b8r6hh0rswLr0t0qxJBK3ga_A6heldUKvknnHKYdHQX7rTJJBs193sPtnC2A7fGXQ-3Hdg_aZSpVwfsbEO0qg_YPjvZaFav7sPnU6cje7PA75--ENeBWkqwRVcpd1XMa1blrL651AuPkM-wOdXDmKosSuJB1kzXrKwMdQOrFs5Yl6tpVRj27avX2CJDklNm1bS4rGilqKGAMj0zLCfqwXTaDj2A86NXZ-OJ17Zq8DIuk6WHh9S1PEMdI4_sloTI_TSWUgthUwhhBJosysPU134o0yDKbd6JIk4Qg8NMcv4Q-rNqho-B5bFI8zARmPg6SsNY-3FO-kuxSW12k-EAvM49at4ocqiuVO1aNe5U5E7lS2XdOQDR-VD9MrOUBY2_nPnCunx9ERLinozeKRpzyns2eH2wRo-aGbG2C2NKgwQfwN7PU2R93GkCcUEkeyLoDCD4F7NxK9lOUgXLJ__9TE_hNu059PWfQd9OLnxu06plugu9lx-D3fbj-QEY6CT5
link.rule.ids 230,315,783,787,888,4511,24130,27938,27939,45599,45693
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV25bttAEB34KJwmSJzDyrkIDFcmxHu9pSDEkGNZMGAZcLdYcpc2DVEURNmAOn9BmvxJPiQfkS_JzJKUkiIHUrBZDkmJM5w3BOe9AdjXCCnKDxKr_OiEqRc4KjPaEW6oUoGInWl6UTwbxYPL8NNVdLUB_ZYLQ22VTe6vc7rN1s1Kt7mb3Vmedy8QfbB6wCwckii8iDdhG88tMNi3eyeng9G60yOumShoT-9dYcugs21e5rYw9quE1wieer9DqM0bapX8E05ZTDp-Ao-bYpL16t_7FDbMdBd2-u0Mt104OK-VqZeHbLwmWlWH7ICdrzWrl8_g84XVkb2bm-8PX4jrQCMl2LztlLvJZxUrM1bdXau5Q8in2Yz6YXRZ5AXxICumKlaUmqaBlXNrrIrlpMw1-_bVqW0NMySnzMpJfl3Sl6KaAsrUVLOMqAeTSbP0HC6PP477A6cZ1eCkgYgXjjmiqeWpUZEJQtxi3wRuEgmhOMcSgmtudBpmfuIq1xeJF2ZYdxoexcZ4R6kIghewNS2nZg9YFvEk82NuYleFiR8pN8pIfynSCVY3qemA07pHzmpFDtm2qt3K2p2S3CldIdGdHeCtD-UvkSURNP5y5Ad0-eoiJMQ96A0lrVnlPUxe92j0so6IlZ0fURnEgw7s_xwiq_1WEyjgRLIngk4HvH8x6zeS7SRVsHj13__pPewMxmdDOTwZnb6GR7THIrH7BrYw0MxbLLEWybvmEfoBSAMm9g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structure%E2%80%93activity+relationships+of+sugar-based+peptidomimetics+as+modulators+of+amyloid+%CE%B2-peptide+early+oligomerization+and+fibrillization&rft.jtitle=European+journal+of+medicinal+chemistry&rft.au=Kaffy%2C+Julia&rft.au=Brinet%2C+Dimitri&rft.au=Soulier%2C+Jean-Louis&rft.au=Khemt%C3%A9mourian%2C+Lucie&rft.date=2014-10-30&rft.pub=Elsevier+Masson+SAS&rft.issn=0223-5234&rft.eissn=1768-3254&rft.volume=86&rft.spage=752&rft.epage=758&rft_id=info:doi/10.1016%2Fj.ejmech.2014.09.031&rft.externalDocID=S0223523414008496
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0223-5234&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0223-5234&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0223-5234&client=summon